TheStreet reaffirmed their buy rating on shares of Amgen (NASDAQ:AMGN) in a research note issued to investors on Wednesday, Analyst Ratings.Net reports. “Amgen (AMGN) has been reiterated by TheStreet Ratings as a buy with a ratings score of A. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, […]
TheStreet Reiterates Buy Rating for Amgen (AMGN) is a post from: Zolmax
The post TheStreet Reiterates Buy Rating for Amgen (AMGN) appeared first on Zolmax.